Compare HIND & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HIND | TOMZ |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | United States | United States |
| Employees | 18 | N/A |
| Industry | | Diversified Commercial Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8M | 12.5M |
| IPO Year | 2016 | 2009 |
| Metric | HIND | TOMZ |
|---|---|---|
| Price | $2.07 | $0.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 16.8K | ★ 534.4K |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,635,927.00 |
| Revenue This Year | N/A | $48.56 |
| Revenue Next Year | N/A | $121.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.75 | $0.50 |
| 52 Week High | $12.87 | $1.20 |
| Indicator | HIND | TOMZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.28 | 54.71 |
| Support Level | $2.02 | $0.53 |
| Resistance Level | $2.43 | $0.81 |
| Average True Range (ATR) | 0.13 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 31.11 | 42.44 |
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.